Cargando…
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is associated with excessive inflammation, as a main reason for severe condition and death. Increased inflammatory cytokines and humoral response to SARS-CoV-2 correlate with COVID-19 immunity and pathogenesis. Importa...
Autores principales: | Widjaja, Gunawan, Turki Jalil, Abduladheem, Sulaiman Rahman, Heshu, Abdelbasset, Walid Kamal, Bokov, Dmitry O., Suksatan, Wanich, Ghaebi, Mahnaz, Marofi, Faroogh, Gholizadeh Navashenaq, Jamshid, Jadidi-Niaragh, Farhad, Ahmadi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245343/ https://www.ncbi.nlm.nih.gov/pubmed/34229864 http://dx.doi.org/10.1016/j.humimm.2021.06.011 |
Ejemplares similares
-
Expression of concern: “Humoral immune mechanisms involved in protective and pathological immunity during COVID-19” [Hum. Immunol. 82(10) (2021) 733–745]
por: Widjaja, Gunawan, et al.
Publicado: (2023) -
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021) -
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021) -
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
por: Marofi, Faroogh, et al.
Publicado: (2021) -
Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022)